US Stock MarketDetailed Quotes
NKTR Nektar Therapeutics
- 1.1350
- +0.0650+6.07%
Trading Nov 27 14:08 ET
209.36MMarket Cap-1351P/E (TTM)
1.1500High1.0800Low1.07MVolume1.0800Open1.0700Pre Close1.19MTurnover0.64%Turnover RatioLossP/E (Static)184.46MShares1.928052wk High4.28P/B188.88MFloat Cap0.455052wk Low--Dividend TTM166.42MShs Float111.3600Historical High--Div YieldTTM6.54%Amplitude0.4126Historical Low1.1140Avg Price1Lot Size
Nektar Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.08%24.12M | 14.59%23.49M | 0.21%21.64M | -2.10%90.12M | 8.45%23.89M | 2.20%24.14M | -5.03%20.5M | -13.00%21.59M | -9.67%92.06M | -11.94%22.02M |
| Operating revenue | -0.08%24.12M | 14.59%23.49M | 0.21%21.64M | -2.10%90.12M | 8.45%23.89M | 2.20%24.14M | -5.03%20.5M | -13.00%21.59M | -9.67%92.06M | -11.94%22.02M |
| Cost of revenue | -64.32%4.44M | 39.26%9.74M | 20.88%8.53M | 56.08%33.77M | 16.85%7.28M | 150.02%12.43M | 36.74%6.99M | 32.83%7.06M | -13.10%21.64M | 1.14%6.23M |
| Gross profit | 68.10%19.69M | 1.81%13.75M | -9.83%13.11M | -19.97%56.35M | 5.14%16.6M | -37.21%11.71M | -18.00%13.51M | -25.49%14.53M | -8.56%70.42M | -16.22%15.79M |
| Operating expense | 19.40%53.99M | 5.64%50.23M | -7.75%47.56M | -38.33%191.58M | -16.61%47.26M | -19.43%45.22M | -24.84%47.55M | -61.70%51.55M | -40.61%310.66M | -56.98%56.68M |
| Selling and administrative expenses | -10.36%18.96M | 14.78%20.51M | -4.42%20.15M | -16.15%77.42M | -21.05%17.32M | -6.16%21.15M | -12.92%17.87M | -22.89%21.08M | -24.84%92.33M | -31.74%21.94M |
| -General and administrative expense | -10.36%18.96M | 14.78%20.51M | -4.42%20.15M | -16.15%77.42M | -21.05%17.32M | -6.16%21.15M | -12.92%17.87M | -22.89%21.08M | -24.84%92.33M | -31.74%21.94M |
| Research and development costs | 45.54%35.03M | 0.14%29.72M | -10.05%27.41M | -47.71%114.16M | -13.81%29.94M | -28.34%24.07M | -30.55%29.68M | -71.59%30.47M | -45.46%218.32M | -65.13%34.74M |
| Operating profit | -2.37%-34.3M | -7.17%-36.49M | 6.93%-34.45M | 43.71%-135.23M | 25.02%-30.66M | 10.59%-33.5M | 27.24%-34.05M | 67.84%-37.02M | 46.15%-240.24M | 63.79%-40.89M |
| Net non-operating interest income expense | -269.53%-2.58M | -91.96%-2.51M | 36.67%-1.31M | 71.42%-6.33M | 43.17%-2.25M | 85.74%-699K | 78.70%-1.31M | 70.98%-2.07M | 50.37%-22.13M | 49.14%-3.96M |
| Non-operating interest income | -34.04%3.44M | -19.50%3.9M | -2.65%4.22M | 180.24%19.01M | 42.41%4.62M | 154.20%5.21M | 342.15%4.85M | 997.47%4.34M | 148.37%6.78M | 845.19%3.24M |
| Non-operating interest expense | 1.86%6.02M | 4.16%6.41M | -13.65%5.53M | -12.37%25.33M | -4.64%6.87M | -15.00%5.91M | -14.89%6.15M | -14.93%6.41M | -38.89%28.91M | -11.39%7.2M |
| Other net income (expense) | 98.58%-166K | 15.76%-13.33M | 98.90%-1.07M | -31.27%-134.71M | 21.36%-9.2M | 30.51%-11.7M | 85.08%-15.82M | -406.69%-98M | -214.83%-102.62M | 53.13%-11.7M |
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 516.64%33.43M | --0 |
| Special income (charges) | 99.60%-46K | 19.72%-13.29M | 99.00%-975K | 5.50%-128.46M | 75.38%-2.85M | 32.50%-11.36M | 84.39%-16.55M | -6,523.32%-97.69M | ---135.93M | ---11.58M |
| -Less：Restructuring and merger&acquisition | -96.12%46K | 50.35%4.96M | -87.80%975K | -79.14%15.33M | -62.81%2.85M | -92.41%1.19M | -93.23%3.3M | 441.90%7.99M | --73.5M | --7.67M |
| -Less:Impairment of capital assets | --0 | -37.16%8.33M | --0 | 70.05%111.83M | -117.96%-1.3M | 747.75%10.17M | -76.88%13.26M | --89.7M | --65.76M | --7.24M |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | -139.09%-1.3M | ---- | ---- | ---- | ---- | --3.33M | ---- |
| Other non- operating income (expenses) | 64.18%-120K | -104.89%-36K | 67.11%-99K | -5,285.34%-6.25M | ---6.35M | ---335K | --736K | ---301K | 99.53%-116K | ---- |
| Income before tax | 19.28%-37.05M | -2.24%-52.32M | 73.13%-36.84M | 24.31%-276.26M | 25.53%-42.11M | 22.47%-45.9M | 67.81%-51.17M | -51.86%-137.08M | 30.25%-364.98M | 61.18%-56.54M |
| Income tax | 114.75%9K | 197.87%46K | 44.44%-35K | -106.22%-200K | -100.92%-29K | 60.65%-61K | -147.00%-47K | -150.00%-63K | 477.20%3.22M | 78,700.00%3.14M |
| Net income | 19.15%-37.06M | -2.43%-52.36M | 73.14%-36.8M | 25.03%-276.06M | 29.50%-42.08M | 22.37%-45.84M | 67.86%-51.12M | -51.58%-137.02M | 29.71%-368.2M | 59.02%-59.69M |
| Net income continuous Operations | 19.15%-37.06M | -2.43%-52.36M | 73.14%-36.8M | 25.03%-276.06M | 29.50%-42.08M | 22.37%-45.84M | 67.86%-51.12M | -51.58%-137.02M | 29.71%-368.2M | 59.02%-59.69M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 19.15%-37.06M | -2.43%-52.36M | 73.14%-36.8M | 25.03%-276.06M | 29.50%-42.08M | 22.37%-45.84M | 67.86%-51.12M | -51.58%-137.02M | 29.71%-368.2M | 59.02%-59.69M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 19.15%-37.06M | -2.43%-52.36M | 73.14%-36.8M | 25.03%-276.06M | 29.50%-42.08M | 22.37%-45.84M | 67.86%-51.12M | -51.58%-137.02M | 29.71%-368.2M | 59.02%-59.69M |
| Basic earnings per share | 25.00%-0.18 | 7.41%-0.25 | 73.97%-0.19 | 26.40%-1.45 | 31.25%-0.22 | 22.58%-0.24 | 68.24%-0.27 | -48.98%-0.73 | 31.12%-1.97 | 59.49%-0.32 |
| Diluted earnings per share | 25.00%-0.18 | 7.41%-0.25 | 73.97%-0.19 | 26.40%-1.45 | 31.25%-0.22 | 22.58%-0.24 | 68.24%-0.27 | -48.98%-0.73 | 31.12%-1.97 | 59.49%-0.32 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data